Molecular Partners Ag (MOLN) Total Non-Current Liabilities (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Total Non-Current Liabilities for 7 consecutive years, with $13289.8 the latest figure, recorded in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 203.34% year-over-year to $13289.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13289.8 (up 203.34% YoY) and the FY2025 annual result came in at $13445.1, down 99.81% from the prior year.
• Total Non-Current Liabilities fell to $13289.8 in Q1 2026 per MOLN's latest filing, from $13445.1 in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MOLN reached as high as $10.5 million in Q2 2022 and fell as low as $4381.2 in Q1 2025.
• A 5-year average of $3.0 million and a median of $13289.8 in 2026 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities slumped 99.86% — and 2026, when it soared 203.34%.
• Year by year, Total Non-Current Liabilities stood at $10.2 million in 2022, then declined by 17.15% to $8.5 million in 2023, then dropped by 17.64% to $7.0 million in 2024, then plunged by 99.81% to $13445.1 in 2025, then slipped by 1.15% to $13289.8 in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $13289.8, $13445.1, and $6099.3 for Q1 2026, Q4 2025, and Q3 2025 respectively.